Business
AstraZeneca likely to run new COVID-19 vaccine trial, CEO says, as questions emerge – Sydney Morning Herald
The company is likely to conduct an additional global vaccine trial after current studies raised questions over its level of protection.
Soriot said he didn’t expect the additional trial to hold up regulatory approvals in the UK and European Union.
Clearance from the US Food and Drug Administration may take longer because the regulator is unlikely to approve the vaccine on the basis of studies conducted elsewhere, especially given the questions over the results, he said. Authorisation in some countries is still expected before the end of the year, he said.
AstraZeneca and its CEO are facing scrutiny as the drugmaker responds to growing…
-
General10 hours agoGroup armed with machetes attack two teenagers outside Luna Park in St Kilda
-
Noosa News22 hours agoInfant crocodile spotted in pool at Sheraton Grand Mirage Resort in Port Douglas, north Queensland
-
Noosa News23 hours agoTensions erupt on Melbourne streets as opposing immigration rallies held across Australian capitals
-
General20 hours agoFormer March for Australia organiser shut down at latest anti-racism rally